Parallax Volatility Advisers’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-5,200
Closed -$601K 2365
2020
Q4
$601K Sell
5,200
-8,400
-62% -$941K ﹤0.01% 1610
2020
Q3
$1.32M Sell
13,600
-8,500
-38% -$978K ﹤0.01% 1870
2020
Q2
$2.72M Buy
22,100
+12,600
+133% +$1.43M ﹤0.01% 1343
2020
Q1
$836K Buy
9,500
+6,500
+217% +$688K ﹤0.01% 1546
2019
Q4
$311K Buy
+3,000
New +$336K ﹤0.01% 1895
2017
Q1
Sell
-55,500
Closed -$6.2M 4953
2016
Q4
$6.2M Hold
55,500
0.01% 586
2016
Q3
$7.37M Buy
+55,500
New +$5.3M 0.01% 550
2016
Q1
Sell
-14,900
Closed -$1.03M 4025
2015
Q4
$1.03M Buy
+14,900
New +$1.21M ﹤0.01% 1267

Other funds holding GWPH

Parallax Volatility Advisers's GWPH Position: Q1 2021 in Review

Parallax Volatility Advisers sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 1,688 shares — an estimated $195K sold.

Parallax Volatility Advisers first reported a position in GWPH in Q4 2015 and held it in 13 quarters. The position peaked at $1.2M in Q3 2018. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

  • Parallax Volatility Advisers reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1,688 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $195K.
  • Parallax Volatility Advisers first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2015 and held it in 13 quarters.
  • Parallax Volatility Advisers's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.2M in Q3 2018.
  • 297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Parallax Volatility Advisers's 13F filing for Q1 2021, filed 14 May 2021.